Trending News
News
News
Spread of Cancer Cells may be Slowed by Targeting of Protein
The spread of cancer cells may be slowed by targeting the protein km23-1, according to researchers at Penn State College of Medicine.
News
Almac and TTP Labtech form Alliance in Fluorescence Lifetime Technology
This will give customers of either party access to a broad range of biological applications coupled with the next generation of microplate reader technology.
News
Ovarian Cancer Stem Cell Study puts Targeted Therapies Within Reach
Researchers at Yale School of Medicine have identified a key link between stem cell factors that fuel ovarian cancer’s growth and patient prognosis.
News
Charles River Laboratories Completes Acquisition of Majority Ownership of Vital River
Charles River Laboratories International, Inc. takes 75% ownership of Vital River, the premier commercial provider of research models and related services in China, and a licensee of Charles River for the last ten years.
News
BGI Reports the First Genome Sequence of Domestic Goat
Work sets a good example for facilitating de novo assembly of large genomes.
News
Grant Will Help Reduce Incidence of Johne's Disease in Dairy Cows
Dangerous bacterium in milk could also be linked to Crohn’s disease in humans.
News
Cheap and Easy Technique to Snip DNA Could Revolutionize Gene Therapy
A simple, precise and inexpensive method for cutting DNA to insert genes into human cells could transform genetic medicine.
News
Priaxon Enters Collaboration with GSK on Protein-Protein-Interactions
Collaboration to establish and develop novel drug discovery approaches to address protein-protein-interactions with small molecules.
News
Chugai and Debiopharm Announce an Exclusive License Agreement for FF284
Chugai will grant Debiopharm an exclusive license to develop and commercialize FF284 in all countries.
News
Trovagene to Study Transrenal BRAF Mutations in Primary and Metastatic Cancers
Study with MD Anderson will compare detection of BRAF mutations in urine to biopsy samples, and monitor therapeutic response, outcomes.
Advertisement